Zonisamide for Heavy Drinkers With Bipolar Disorder.

Trial Profile

Zonisamide for Heavy Drinkers With Bipolar Disorder.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2017

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Alcoholism; Bipolar disorders
  • Focus Biomarker; Therapeutic Use
  • Acronyms ZNS-BP
  • Most Recent Events

    • 13 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Sep 2016.
    • 13 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed to 1 Apr 2016.
    • 19 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top